| Safety population (N = 199) |
---|---|
Hematologic AEs, n (%) | Â |
  Anemia | 52 (26.1) |
  Neutropenia | 50 (25.1) |
  Thrombocytopenia | 29 (14.6) |
  Leukopenia | 19 (9.5) |
Non-hematologic AEs, n (%) | Â |
  Pneumonia | 26 (13.1) |
  Upper respiratory tract infection | 8 (4.0) |
  Fatigue | 8 (4.0) |
  Hypokalemia | 14 (7.0) |
  Hyperglycemia | 5 (2.5) |
  Hypocalcemia | 5 (2.5) |
Investigations | Â |
  Neutrophil count decreased | 17 (8.5) |
  Platelet count decreased | 14 (7.0) |
  White blood cell count decreased | 14 (7.0) |
Discontinuation due to AEs, n (%) | 18 (9.0) |